These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29728335)

  • 21. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.
    Brunetti ND; Troccoli R; Correale M; Pellegrino PL; Di Biase M
    Int J Cardiol; 2006 May; 109(2):248-56. PubMed ID: 16055214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin.
    Dhar I; Siddique S; R Pedersen E; F T Svingen G; Lysne V; Olsen T; Nilsen DW; Nordrehaug JE; Midttun Ø; M Ueland P; S Tell G; K Nygård O
    Heart; 2020 Jul; 106(14):1073-1079. PubMed ID: 32398245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events.
    De Chiara B; Mafrici A; Campolo J; Famoso G; Sedda V; Parolini M; Cighetti G; Lualdi A; Fiorentini C; Parodi O
    Coron Artery Dis; 2007 Mar; 18(2):77-82. PubMed ID: 17301597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
    Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
    Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kynurenines as predictors of acute coronary events in the Hordaland Health Study.
    Eussen SJ; Ueland PM; Vollset SE; Nygård O; Midttun Ø; Sulo G; Ulvik A; Meyer K; Pedersen ER; Tell GS
    Int J Cardiol; 2015; 189():18-24. PubMed ID: 25885868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study.
    Xiao Y; Zhang Y; Wang M; Li X; Su D; Qiu J; Li D; Yang Y; Xia M; Ling W
    Am J Clin Nutr; 2013 Nov; 98(5):1162-9. PubMed ID: 24004894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of computed tomographic coronary angiography in patients with acute myocardial infarction versus stable angina pectoris: a preliminary report.
    Chen SJ; Kuo LT; Wang CH; Cherng WJ; Yang NI; Cheng CW
    Chang Gung Med J; 2011; 34(3):268-77. PubMed ID: 21733356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease.
    Johnson J; Manouras A; Bergholm F; Brodin LÅ; Agewall S; Henareh L
    Clin Physiol Funct Imaging; 2014 Sep; 34(5):389-96. PubMed ID: 24438358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
    Zylberstein DE; Bengtsson C; Björkelund C; Landaas S; Sundh V; Thelle D; Lissner L
    Circulation; 2004 Feb; 109(5):601-6. PubMed ID: 14769681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of the new gaseous transmitter H2S in patients with coronary heart disease].
    Jiang HL; Wu HC; Li ZL; Geng B; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):951-4. PubMed ID: 16109547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.
    Pilz S; Scharnagl H; Tiran B; Seelhorst U; Wellnitz B; Boehm BO; Schaefer JR; März W
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2542-7. PubMed ID: 16595593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease.
    Liu Y; Li X; Peng D; Tan Z; Liu H; Qing Y; Xue Y; Shi GP
    Am J Cardiol; 2009 Feb; 103(4):476-81. PubMed ID: 19195505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of platelet adhesiveness in patients with coronary artery disease and acute myocardial infarction using the platelet adhesion assay (PADA).
    Walter T; Szabo S; Kazmaier S; Suselbeck T; Nowak G; Borggrefe M; Hoffmeister HM; Dempfle CE
    Clin Lab; 2011; 57(5-6):315-20. PubMed ID: 21755820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
    Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J
    Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study.
    Coppola G; Rizzo M; Abrignani MG; Corrado E; Di Girolamo A; Braschi A; Braschi G; Novo S
    Ital Heart J; 2005 Apr; 6(4):315-22. PubMed ID: 15902930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.